Sab Biotherapeutics, Inc. · NASDAQ:SABS
Perceptive Advisors LLC reported a 7.30% stake in Sab Biotherapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Perceptive Advisors LLC reported a 7.30% stake in Sab Biotherapeutics, Inc., 6,627,501 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 7.30%
- Shares
- 6,627,501
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 7.30% | 6,627,501 |
| Joseph Edelman | 7.30% | 6,627,501 |
| Perceptive Life Sciences Master Fund, Ltd. | 7.30% | 6,627,501 |
Source
Related
- Sab Biotherapeutics, Inc.
- Perceptive Advisors LLC
- Sab Biotherapeutics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G · Perceptive Advisors LLC · Jan 22, 2026
- Form 4 · Kropotova Alexandra · Sep 18, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Caligan Partners LP · Aug 14, 2026